Hong Kong Sanatorium & Hospital
Hong Kong
NCT Number: NCT04416061
Hong Kong public healthcare system is facing tremendous pressure under the COVID-19 pandemic. As the virus spread in Hong Kong, Hong Kong Sanatorium & Hospital (HKSH) is one of the first private hospitals which immediately provide reliable and rapid COVID-19 test -- Reverse Transcription Polymerase Chain Reaction (RT-PCR). Early provision of the RT-PCR screening test for COVID-19 not only facilitates identification of COVID-19 but also contains the spread of the virus in the community and frontline medical staff.
Since description of role of private hospital in Hong Kong amid COVID-19 pandemic is lacking, this study will describe COVID-19 screening algorithm and methodology. A retrospective analysis on clinical characteristics, laboratory findings as well as outcome of patients who underwent COVID-19 test in HKSH is also performed.
Looking for future studies?
Notify MeAll sexes
Observational
Hong Kong
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
COVID 19 Diagnostic Test
Time frame: 1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong
Proportion of asymptomatic subjects (%) who underwent COVID 19 test
Time frame: 1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong
Proportion of subjects (%) with recent contact history
Time frame: 1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong
Proportion of subjects (%) with recent travel history
Hong Kong Sanatorium & Hospital
Industry
The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic: A Descriptive Study of Patients With SARS-CoV-2 RT-PCR Performed
Acronym: COVID-19
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06821139
COVID, COVID - 19
Surrey, British Columbia, Canada
View Trial DetailsNCT03590327
Apathy, COVID
Little Rock, Arkansas, United States
View Trial DetailsNCT04447833
ARDS, Human, COVID
Uppsala, Sweden
View Trial DetailsNCT04367545
COVID, RT-ddPCR Multiplex
Rouen, France
View Trial Details